Barclays’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $808K | Buy |
71,108
+8,412
| +13% | +$95.6K | ﹤0.01% | 2788 |
|
|
2025
Q1 | $629K | Buy |
62,696
+44,199
| +239% | +$443K | ﹤0.01% | 2707 |
|
|
2024
Q4 | $328K | Buy |
18,497
+5,634
| +44% | +$99.9K | ﹤0.01% | 3281 |
|
|
2024
Q3 | $264K | Buy |
12,863
+3,463
| +37% | +$71.1K | ﹤0.01% | 3343 |
|
|
2024
Q2 | $219K | Buy |
+9,400
| New | +$219K | ﹤0.01% | 3005 |
|